Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer
Oh, Jonathan, Barve, Minal, Matthews, Carolyn M, Koon, E. Colin, Heffernan, Thomas P, Fine, Bruce, Grosen, Elizabeth, Bergman, Melanie K, Fleming, Evelyn L, DeMars, Leslie R, West, Loyd, Spitz, Daniel L, Goodman, Howard, Hancock, Kenneth C, Wallraven, Gladice, Kumar, Padmasini, Bognar, Ernest, Manning, Luisa, Pappen, Beena O, Adams, Ned, Senzer, Neil, Nemunaitis, John
Published in Gynecologic oncology (01.12.2016)
Published in Gynecologic oncology (01.12.2016)
Get full text
Journal Article